ID=H0843
URL=http://hiv-web.lanl.gov/content/hiv-db/REVIEWS/articles/brander99/brander99.html
SIZE=41492
DATE=11/07/2002
TIME=17:08:37
DATASET=Biology
HTML=  
<html>
  <head>
    <title></title>
      <style type="text/css">
	<!--
	  span.red {color: red}
	  span.green {color: green}
          span.small {size:"-1"}
	  input.lavender {background: lavender;
			  color: green}
	  ul.tip {list-style-type: none} 
	  .a11 {color: black; 
                font-size: 11pt; 
                font-weight: normal; 
                text-decoration: none; 
                font-family: Arial, Helvetica, sans-serif}
          a:link {color: blue; 
                  text-decoration : none; 
                  font-weight: normal}
	  a:visited {color : blue;
                     text-decoration : none;
                     font-weight : normal}
          a:hover {color: brown; 
                   text-decoration : none; 
                   font-weight: normal}
#pup {position:absolute; visibility:hidden; z-index:200; width:130; }
//-->
      </style>	
  </head>
  <body bgcolor="white">
    <table bgcolor="white" width="100%" border=0 cellspacing=0 cellpadding=3>
      <tr valign="top">
	<td width="10%" bgcolor="#eaeaea">
               <!--
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">

<HTML>

<HEAD>
  <TITLE>
    HIV sequence database navigation frame
  </TITLE>
</HEAD>


<BODY> 
	BACKGROUND="" 
	BGCOLOR="#eaeaea" 
	TEXT="#000000" 
	LINK="#0000ff" 
	VLINK="#800080" 
	ALINK="#ff0000"
-->

<A HREF="/content/hiv-db/mainpage.html">
	
<IMG SRC="/content/hiv-db/IMAGES/VirusTransparent.gif" BORDER=0></A>

<P>
<CENTER>
</CENTER>

<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/headerDatabases.gif" BORDER=0></A><BR>

<A HREF="/content/hiv-db/mainpage.html" 
	onMouseOver="document.Sequence.src='/content/hiv-db/NAVIFRAME/YELLOW/_SequenceDB.gif' "
	onMouseOut="document.Sequence.src='/content/hiv-db/NAVIFRAME/YELLOW/SequenceDB.gif' " >
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/SequenceDB.gif" BORDER=0 NAME="Sequence"></A><BR>

<A HREF="http://resdb.lanl.gov/Resist_DB/default.htm" 
	onMouseOver="document.Resistance.src='/content/hiv-db/NAVIFRAME/YELLOW/_ResistanceDB.gif' "
	onMouseOut="document.Resistance.src='/content/hiv-db/NAVIFRAME/YELLOW/ResistanceDB.gif'">
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/ResistanceDB.gif" BORDER=0 NAME="Resistance"></A><BR>

<A HREF="/content/immunology/index" 
	onMouseOver="document.Immunology.src='/content/hiv-db/NAVIFRAME/YELLOW/_ImmunologyDB.gif' "
	onMouseOut="document.Immunology.src='/content/hiv-db/NAVIFRAME/YELLOW/ImmunologyDB.gif' ">
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/ImmunologyDB.gif" BORDER=0 NAME="Immunology"></A><BR>

<A HREF="/content/vaccine/html/index.html" 
	onMouseOver="document.VaccineTrials.src='/content/hiv-db/NAVIFRAME/YELLOW/_VaccinetrialsDB.gif' "
	onMouseOut="document.VaccineTrials.src='/content/hiv-db/NAVIFRAME/YELLOW/VaccinetrialsDB.gif' ">
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/VaccinetrialsDB.gif" BORDER=0 NAME="VaccineTrials"></A><BR>

<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/bottom.gif" BORDER=0></A><BR>

<P>

<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/headerPublications.gif" BORDER=0></A><BR>

<A HREF="/content/hiv-db/HTML/FAQ.html" 
	onMouseOver="document.Faq.src='/content/hiv-db/NAVIFRAME/YELLOW/_FAQ.gif' "
	onMouseOut="document.Faq.src='/content/hiv-db/NAVIFRAME/YELLOW/FAQ.gif' ">
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/FAQ.gif" BORDER=0 NAME="Faq"></A><BR>

<A HREF="/content/hiv-db/ALIGN_CURRENT/ALIGN-INDEX.html" 
	onMouseOver="document.Alignments.src='/content/hiv-db/NAVIFRAME/YELLOW/_Alignments.gif' "
	onMouseOut="document.Alignments.src='/content/hiv-db/NAVIFRAME/YELLOW/Alignments.gif' ">
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/Alignments.gif" BORDER=0 NAME="Alignments"></A><BR>

<A HREF="/content/hiv-db/HTML/Tutorials.html" 
	onMouseOver="document.Tutorials.src='/content/hiv-db/NAVIFRAME/YELLOW/_Tutorials.gif' "
	onMouseOut="document.Tutorials.src='/content/hiv-db/NAVIFRAME/YELLOW/Tutorials.gif' ">
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/Tutorials.gif" BORDER=0 NAME="Tutorials"></A><BR>

<A HREF="/content/hiv-db/REVIEWS/reviews.html" 
	onMouseOver="document.Reviews.src='/content/hiv-db/NAVIFRAME/YELLOW/_Reviews.gif' "
	onMouseOut="document.Reviews.src='/content/hiv-db/NAVIFRAME/YELLOW/Reviews.gif' ">
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/Reviews.gif" BORDER=0 NAME="Reviews"></A><BR>

<A HREF="/content/hiv-db/HTML/compendium.html" 
	onMouseOver="document.Compendia.src='/content/hiv-db/NAVIFRAME/YELLOW/_Compendia.gif' "
	onMouseOut="document.Compendia.src='/content/hiv-db/NAVIFRAME/YELLOW/Compendia.gif' ">
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/Compendia.gif" BORDER=0 NAME="Compendia"></A><BR>

<A HREF="/content/hiv-db/HTML/links.html" 
	onMouseOver="document.Links.src='/content/hiv-db/NAVIFRAME/YELLOW/_Links.gif' "
	onMouseOut="document.Links.src='/content/hiv-db/NAVIFRAME/YELLOW/Links.gif' ">
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/Links.gif" BORDER=0 NAME="Links"></A><BR>

<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/bottom.gif" BORDER=0></A><BR>

<P>

<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/headerSequenceDB.gif" BORDER=0></A><BR>

<!--
<A HREF="/content/hiv-db/MAP/hivmap.html" 
-->
<A HREF="/content/hiv-db/combined_search/search" 
	onMouseOver="document.Hivmap.src='/content/hiv-db/NAVIFRAME/YELLOW/_Search&Align.gif'"
	onMouseOut="document.Hivmap.src='/content/hiv-db/NAVIFRAME/YELLOW/Search&Align.gif'">
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/Search&Align.gif" BORDER=0 NAME="Hivmap"></A><BR>

<!--
<A HREF="/cgi-bin/hivDB3/public/wdb/ssampublic" 
-->
<A HREF="/content/hiv-db/combined_search/search" 
	onMouseOver="document.Searchdb.src='/content/hiv-db/NAVIFRAME/YELLOW/_SearchDB.gif' "
	onMouseOut="document.Searchdb.src='/content/hiv-db/NAVIFRAME/YELLOW/SearchDB.gif' ">
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/SearchDB.gif" BORDER=0 NAME="Searchdb"></A><BR>

<A HREF="/content/hiv-db/HTML/tools.html" 
	onMouseOver="document.Tools.src='/content/hiv-db/NAVIFRAME/YELLOW/_Tools.gif'"
	onMouseOut="document.Tools.src='/content/hiv-db/NAVIFRAME/YELLOW/Tools.gif'">
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/Tools.gif" BORDER=0 NAME="Tools"></A><BR>

<A HREF="/content/hiv-db/BASIC_BLAST/basic_blast.html" 
	onMouseOver="document.Hivblast.src='/content/hiv-db/NAVIFRAME/YELLOW/_HIV-BLAST.gif' "
	onMouseOut="document.Hivblast.src='/content/hiv-db/NAVIFRAME/YELLOW/HIV-BLAST.gif' ">
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/HIV-BLAST.gif" BORDER=0 NAME="Hivblast"></A><BR>

<A HREF="http://linker.lanl.gov/RIP/RIPsubmit.html" 
	onMouseOver="document.Rip.src='/content/hiv-db/NAVIFRAME/YELLOW/_Recombination.gif' "
	onMouseOut="document.Rip.src='/content/hiv-db/NAVIFRAME/YELLOW/Recombination.gif' " >
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/Recombination.gif" BORDER=0 NAME="Rip"></A><BR>

<A HREF="/content/hiv-db/SNAP/WEBSNAP/SNAP.html" 
	onMouseOver="document.Snap.src='/content/hiv-db/NAVIFRAME/YELLOW/_Syn-Nonsyn.gif' "
	onMouseOut="document.Snap.src='/content/hiv-db/NAVIFRAME/YELLOW/Syn-Nonsyn.gif' ">
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/Syn-Nonsyn.gif" BORDER=0 NAME="Snap"></A><BR>

<A HREF="/content/hiv-db/HYPERMUT/hypermut.html" 
	onMouseOver="document.Hypermut.src='/content/hiv-db/NAVIFRAME/YELLOW/_Hypermut.gif' "
	onMouseOut="document.Hypermut.src='/content/hiv-db/NAVIFRAME/YELLOW/Hypermut.gif' ">
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/Hypermut.gif" BORDER=0 NAME="Hypermut"></A><BR>

<A HREF="/content/hiv-db/PCOORD/PCOORD.html" 
	onMouseOver="document.Pcoord.src='/content/hiv-db/NAVIFRAME/YELLOW/_PCOORD.gif' "
	onMouseOut="document.Pcoord.src='/content/hiv-db/NAVIFRAME/YELLOW/PCOORD.gif' " >
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/PCOORD.gif" BORDER=0 NAME="Pcoord"></A><BR>
    
<A HREF="/content/hiv-db/SUDI/sudi.html" 
	onMouseOver="document.SUDI.src='/content/hiv-db/NAVIFRAME/YELLOW/_SUDI.gif' "
	onMouseOut="document.SUDI.src='/content/hiv-db/NAVIFRAME/YELLOW/SUDI.gif' ">
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/SUDI.gif" BORDER=0 NAME="SUDI"></A><BR>

<A HREF="/content/hiv-db/CONTAM/TreeMaker/TreeMaker.html" 
	onMouseOver="document.Treemaker.src='/content/hiv-db/NAVIFRAME/YELLOW/_TreeMaker.gif' "
	onMouseOut="document.Treemaker.src='/content/hiv-db/NAVIFRAME/YELLOW/TreeMaker.gif' " >
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/TreeMaker.gif" BORDER=0 NAME="Treemaker"></A><BR>

<A HREF="/content/hiv-db/geography/map_right.html" 
	onMouseOver="document.Geography.src='/content/hiv-db/NAVIFRAME/YELLOW/_Geography.gif' "
	onMouseOut="document.Geography.src='/content/hiv-db/NAVIFRAME/YELLOW/Geography.gif' ">
	
<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/Geography.gif" BORDER=0 NAME="Geography"></A><BR>

<IMG SRC="/content/hiv-db/NAVIFRAME/YELLOW/bottom.gif" BORDER=0></A><BR>

<!--
<br>
<small>
<small>
&nbsp;<a href="/content/hiv-db/combined_search/search">Combined Search</a>
</small>
</small>
</CENTER>
-->
<BR>
<BR>

<center>
<small>
<small>
<A HREF="http://www.lanl.gov/misc/disclaimer.html" >Disclaimer/Privacy</A>
</small>
</small>
<FONT FACE="Arial, Helvetica, sans-serif" SIZE="-2">
</FONT>
</center>

<!--
</BODY>
</HTML>
-->


        </td>
	<td>
	  <table border="0" cellspacing="0" cellpadding="3">
	    <tr><td>
            </td></tr>
	    <tr><td><html>

<head>
<meta http-equiv="Content-Type"
content="text/html; charset=iso-8859-1">
<meta name="GENERATOR" content="Microsoft FrontPage Express 2.0">
<title>HIV Sequence Database: Hypermutation Submission Form</title>
</head>

<body bgcolor="#FFFFFF">

<p align="center"><br>
<img src="../../../IMAGES/newtoplogo2.gif"> </p>

<p align="center"><font size="5"><strong>Recent Advances in HIV-1
CTL Epitope Characterization</strong></font></p>

<hr noshade>

<p><font size="2"><strong>Christian Brander and Philip J. R.
Goulder </strong></font></p>

<p><font size="2"><em>AIDS Research Center, Massachusetts General
Hospital, </em></font></p>

<p><font size="2"><em>149 13th Street, Room 5234, </em></font></p>

<p><font size="2"><em>Charlestown, MA 02129, USA, </em></font></p>

<p><font size="2"><em>and Harvard Medical School Boston, MA USA</em>
</font></p>

<p>&nbsp;</p>

<p><strong>Updated November 1999 </strong></p>

<p>Since the last update of the Los Alamos HIV Immunology
Database in 1998, the role of CTL in HIV and SIV infection has
been further recognized as a beneficial and essential part of the
host immune response against these viruses [Schmitz(1999),
Brander &amp; Walker(1999b)]. As the full picture of the precise
role of HIV specific CTL is still emerging, it becomes clear that
under certain circumstances these cells are able to contribute
significantly to the control of viral replication in infected
individuals [Ogg(1998)]. Along with more sophisticated techniques
to detect and quantify CTL responses, including ELISPOT and
Tetramer methodologies [McMichael &amp; O'Callaghan(1998),
Goulder(2000a)], more detailed analyses of the genetic background
of infected individuals may provide new insights into HIV
pathogenesis [Tang(1999), Carrington(1999)]. </p>

<p>The identification of HLA alleles which are associated with
more rapid or slower disease progression, may now be linked to
the importance and dominance of certain CTL epitopes. It is
intriguing that thus far, only HLA-B alleles have been
consistently associated with HIV-1 disease progression, which may
be due to the relative distance of HLA-A genes to the central
part of the MHC region containing HLA class III genes involved in
the antigen processing. It is interesting that for some alleles
(e.g. HLA-A1) no optimal epitopes have been defined, despite
relative high frequencies in diverse populations. The mechanisms
for HLA association and disease progression and the pattern of
class I alleles that present HIV-derived CTL epitopes, including
HLA alleles that are frequent in non-Caucasoid populations,
require further investigation and these results will also need to
be considered for the design of (epitope based) vaccines. </p>

<p>The current update of the list of optimal CTL epitope has
undergone a few improvements: </p>

<p>There are an increased number of epitopes listed and the
nomenclature for the HLA alleles has been updated. Accordingly,
the order of the epitopes may have changed slightly: e.g. the
`HLA-B62' allele is now listed as HLA-B*1501. The data for the
HLA class I binding motifs have been added for as many HLA
alleles as possible and are mainly based on the database by
Rammensee and co-workers [Rammensee(1999)].</p>

<p>This year's update has also been modified as more attention
was given to epitopes that were contributed by personal
communication. The individuals who kindly submitted their
unpublished epitopes over the last few years were asked for more
detailed titration/truncation data. We have now highlighted with
an asterisk (*) those epitopes contributed as personal
communications for which we had a chance to review the titration
data. As a consequence of this enhanced scrutiny, a number of
epitopes (mainly from our own laboratories) had to be removed
from the list of optimal epitopes since the characterization did
not fulfill all the stricter inclusion criteria. We would like to
define these inclusion criteria still further as: a) detailed HLA
restriction, possibly including subtype analysis; and b)
titration curves with single amino acid truncated, longer and
shorter versions of the epitope. In this regard, we found that
titration curves with truncated peptides can easily be performed
by ELISPOT, even at low numbers of CTL clones added per well (M.
Altfeld, unpublished). In addition, an HLA-B35 restricted epitope
in gp120 reported by Shiga et al., [Shiga(1996)], was included
without peptide titrations being performed, since it has been
used successfully in tetramer staining procedure in later studies
[Ogg(1999)]. </p>

<p>Some of the newly added epitopes deserve special attention as
these are the first ones of a series of epitopes that have been
identified in individuals with acute HIV-1 infection (M. Altfeld,
unpublished data). These preliminary studies suggest that
responses which are immunodominant in acute infection may differ
from those seen in chronic infection. These findings will need
more confirmation, but may also help to explain the
immunodominance of certain epitopes in chronic infection. One
possible explanation for these different responses could be that
the responses elicited during acute infection are diminished over
time (for various reasons, [Brander &amp; Walker(1999b)] and that
a new generation of epitopes that may be more resistant to CTL
escape remain detectable in chronic infection. In this regard,
the clustering of CTL epitopes to certain regions of the HIV
genome may need to be revisited and more studies in acute
infected individuals may help to complete the picture of the role
CTL play in HIV infection. </p>

<p>We would like to express our gratitude to the large number of
researchers in the field who continuously contribute to this
database. We very much welcome any criticism, comments and
additions to this list since we are sure that some epitopes will
unintentionally escape our attention, despite close monitoring of
the literature. Please write or call us with any comments at: </p>
<p>
<pre>
Christian Brander 			Bruce D. Walker 
phone: (617) 724-5789 			phone: (617) 724-8332 
FAX:   (617) 726-5411 			FAX: (617) 726-4691
brander@helix.mgh.harvard.edu 		bwalker@helix.mgh.harvard.edu

Philip J.R. Goulder 			Bette Korber 
phone: (617) 726-5787 			phone: (505) 665-4453 
FAX:   (617) 726-5411 			FAX: (505) 665-3493
goulder@helix.mgh.harvard.edu 		btk@t10.lanl.gov 
</pre>
<P>
<img src="./3.gif">
<P>
<img src="./4.gif">
<P>
<img src="./5.gif">
<P>
<img src="./6.gif">
<P>
<img src="./7.gif">
<P>
<img src="./8.gif">
<P>
<img src="./9.gif">
<P>
<img src="./10.gif">
<P>
<img src="./11.gif">
<P>
<img src="./12.gif">
<P>
<b><font size="+2">REFERENCES</font></b>
<P>
[Alexander-Miller (1996)]<br>
M.A. Alexander-Miller, K.C. Parker, T.Tsukui, C.D. Pendleton, J.E. Coligan, & J.A. Berzofsky.
Molecular analysis of presentation by HLA-A2.1 of a promiscuously binding V3 loop peptide from the HIV-1 Envelope protein to
human cytotoxic T lymphocytes.
<i> Int Immunol</i> <b>8</b>:641--649, 1996.

<P>[Barber (1995)]<br>
L.D. Barber, B.Gillece-Castro, L.Percival, X.Li, C.Clayberger,
  &P.Parham.
 Overlap in the repertoires of peptides bound in vivo by a group of
  related class I HLA-B allotypes.
 <i> Curr Biol</i> <b>5</b>:179--90, 1995.

<P>[Barber (1997)]<br>
L.D. Barber, L.Percival, K.L. Arnett, J.E. Gumperz, L.Chen, \&
  P.Parham.
 Polymorphism in the $\alpha$1 Helix of the HLA-B Heavy Chain Can
  Have an Overriding Influence on Peptide-Binding Specificity.
 <i> J Immunol</i> <b>158</b>:1660--1669, 1997.

<P>[Barouch (1995)]<br>
D.Barouch, T.Friede, S.Stevanovic, L.Tussey, K.Smith,
  S.Rowland-Jones, V.Braud, A.McMichael, &H.G. Rammensee.
 HLA-A2 subtypes are functionally distinct in peptide binding and
  presentation.
 <i> J Exp Med</i> <b>182</b>:1847--56, 1995.

<P>[Bauer (1997)]<br>
M.Bauer, M.Lucchiari-Hartz, R.Maier, G.Haas, B.Autran,
  K.Eichmann, R.Frank, B.Maier, &A.Meyerhans.
 Structural constraints of HIV-1 Nef may curtail escape from
  HLA-B7-restricted CTL recognition.
 <i> Immunol Lett</i> <b>55</b>:119--22, 1997.

<P>[Bertoletti (1998)]<br>
A.Bertoletti, F.Cham, S.McAdam, T.Rostron, S.Rowland-Jones,
  S.Sabally, T.Corrah, K.Ariyoshi, &H.Whittle.
 Cytotoxic T cells from human immunodeficiency virus type 2-infected
  patients frequently cross-react with different human immunodeficiency virus
  type 1 Clades.
 <i> J Virol</i> <b>72</b>:2439--2448, 1998.

<P>[Borrow (1997)]<br>
P.Borrow, H.Lewicki, X.Wei, M.S. Horwitz, N.Peffer, H.Meyers,
  J.A. Nelson, J.E. Gairin, B.H. Hahn, M.B. Oldstone, &G.M.
  Shaw.
 Anti-viral pressure exerted by HIV-1-specific cytotoxic T
  lymphocytes (CTLs) during primary infection demonstrated by rapid selection
  of CTL escape virus.
 <i> Nat Med</i> <b>3</b>:205--11, 1997.

<P>[Brander &Walker(1999)]<br>
C.Brander &B.D. Walker.
 T lymphocyte responses in HIV-1 infection: implications for vaccine
  development.
 <i> Curr Opin Immunol</i> <b>11</b>:451--9, 1999.

<P>[Buseyne (1993)]<br> 
F.Buseyne, M.McChesney, F.Porrot, S.Kovarik, B.Guy, \&
  Y.Riviere.
 Gag-specific cytotoxic T lymphocytes from human immunodeficiency
  virus type 1 infected individuals: gag epitopes are clustered in three
  regions of the p24 gag protein.
 <i> J Virol</i> <b>67</b>:694--702, 1993.

<P>[Buseyne (1997)]<br>
F.Buseyne, S.Stevanovic, H.Rammensee, &Y.Riviere.
 Characterization of an HIV-1 p24 gag epitope recognized by a CD8+
  cytotoxic T-cell clone.
 <i> Immunol Lett</i> <b>55</b>(3):145--149, 1997.

<P>[Carrington (1999)]<br>
M.Carrington, G.W. Nelson, M.P. Martin, T.Kissner, D.Vlahov,
  J.J. Goedert, R.Kaslow, S.Buchbinder, K.Hoots, &S.J.
  O'Brien.
 HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage
  [see comments].
 <i> Science</i> <b>283</b>:1748--52, 1999.

<P>[Culmann (1991)]<br>
B.Culmann, E.Gomard, M.-P. Kieny, B.Guy, F.Dreyfus, A.-D.
  Saimot, D.Sereni, D.Sicard, &J.-P. Levy.
 Six epitopes with human cytotoxic CD8+ cells in the central region
  of the HIV-1 Nef protein.
 <i> J Immunol</i> <b>146</b>:1560--1565, 1991.

<P>[Culmann-Penciolelli (1994)]<br>
B.Culmann-Penciolelli, S.Lamhamedi-Cherradi, I.Couillin, N.Guegan,
  J.P. Levy, J.G. Guillet, &E.Gomard.
 Identification of multirestricted immunodominant regions recognized
  by cytolytic T lymphocytes in the human immunodeficiency virus type 1 Nef
  protein (See comments in J Virol 1995 Jan;69(1):618).
 <i> J Virol</i> <b>68</b>:7336--43, 1994.

<P>[Dai (1992)]<br>
L.C. Dai, K.West, R.Littaua, K.Takahashi, &F.A. Ennis.
 Mutation of human immunodeficiency virus type 1 at amino acid 585 on
  gp41 results in loss of killing by CD8+ A24-restricted cytotoxic T
  lymphocytes.
 <i> J Virol</i> <b>66</b>:3151--3154, 1992.

<P>[DiBrino (1993)]<br>
M.DiBrino, K.C. Parker, &J.S. etal.
 Endogenous peptides bound to HLA-A3 possess a specific combination
  of anchor residues that permit identification of potential antigenic
  peptides.
 <i> Proc Natl Acad Sci USA</i> <b>90</b>:1508--1512, 1993.

<P>[DiBrino (1994a)]<br>
M.DiBrino, K.C. Parker, D.H. Margulies, J.Shiloach, R.V. Turner,
  M.Garfield, W.E. Biddison WE, &J.E. Coligan.
 The HLA-B14 peptide binding site can accommodate peptides with
  different combinations of anchor residues.
 <i> J Biol Chem</i> <b>269</b>, 1994a.

<P>[DiBrino (1994b)]<br>
M.DiBrino, K.C. Parker, J.Shiloach, R.V. Turner, T.Tsuchida,
  M.Garfield, W.E. Biddison, &J.E. Coligan.
 Endogenous peptides with distinct amino acid anchor residue motifs
  bind to HLA-A1 and HLA-B8.
 <i> J Immunol</i> <b>152</b>:620--31, 1994b.

<P>[Dorrell (1999)]<br>
L.Dorrell, T.Dong, G.S. Ogg, S.Lister, S.McAdam, T.Rostron,
  C.Conlon, A.J. McMichael, &S.L. Rowland-Jones.
 Distinct recognition of non-clade B human immunodeficiency virus
  type 1 epitopes by cytotoxic T lymphocytes generated from donors infected in
  Africa.
 <i> J Virol</i> <b>73</b>:1708--14, 1999.

<P>[Dumrese (1998)]<br>
T.Dumrese, S.Stevanovic, F.H. Seeger, N.Yamada, Y.Ishikawa,
  K.Tokunaga, M.Takiguchi, &H.Rammensee.
 HLA-A26 subtype A pockets accommodate acidic N-termini of ligands.
 <i> Immunogenetics</i> <b>48</b>:350--3, 1998.

<P>[Dupuis (1995)]<br>
M.Dupuis, S.K. Kundu, &T.C. Merigan.
 Characterization of HLA-A*0201-restricted cytotoxic T-cell epitopes
  in conserved regions of the HIV type 1 gp160 protein.
 <i> J Immunol</i> <b>155</b>:2232--2239, 1995.

<P>[Englehard (1993)]<br>
V.H. Englehard, E.L. Huczko, &W.Bodner et al.
 Peptides bound to HLA-B7 determined by mass spectrometry.
 <i> J Cell Biochem Suppl 1993</i> <b>17C</b>:56, 1993.

<P>[Falk (1991)]<br>
K.Falk, O.Rotzschke, S.Stevanovic, G.Jung, &H.-G. Rammensee.
 Allele-specific motifs revealed by sequencing of self-peptides
  eluted from MHC molecules.
 <i> Nature</i> <b>351</b>:290--296, 1991.

<P>[Falk (1993)]<br>
K.Falk, O.Rotzschke, B.Grahovac, D.Schendel, S.Stevanovic,
  G.Jung, &H.G. Rammensee.
 Peptide motifs of HLA-B35 and -B37 molecules [published erratum
  appears in Immunogenetics 1994;39(5):379].
 <i> Immunogenetics</i> <b>38</b>:161--2, 1993.

<P>[Falk (1994)]<br>
K.Falk, O.Rotzschke, &B.Grahavac.
 Allele-specific peptide motifs of HLA-C molecules.
 <i> Proc Natl Acad Sci USA</i> <b>90</b>:12005--12009, 1994.

<P>[Falk (1995a)]<br>
K.Falk, O.Rotzschke, M.Takiguchi, V.Gnau, S.Stevanovic,
  G.Jung, &H.Rammensee.
 Peptide motifs of HLA-B38 and B39 molecules.
 <i> Immunogenetics</i> <b>41</b>:162--164, 1995a.

<P>[Falk (1995b)]<br>
K.Falk, O.Rotzschke, M.Takiguchi, V.Gnau, S.Stevanovic,
  G.Jung, &H.Rammensee.
 Peptide motifs of HLA-B58, B60, B61, and B62 molecules.
 <i> Immunogenetics</i> <b>41</b>:165--168, 1995b.

<P>[Gotch (1993)]<br>
F.Gotch, S.N. McAdam, &C.E. Allsopp et al.
 Cytotoxic T-cells in HIV-2 seropositive Gambians. Identification of
  a virus specific MHC-restricted peptide epitope.
 <i> J Immunol</i> <b>151</b>:3361--3369, 1993.

<P>[Goulder (1996a)]<br>
P.Goulder, C.Conlon, K.McIntyre, &A.McMichael.
 Identification of a novel human leukogen antigen A26-restricted
  epitope in a conserved region of Gag.
 <i> AIDS</i> <b>10(12)</b>:1441--1443, 1996a.

<P>[Goulder (1996b)]<br>
P.J.R. Goulder, M.Bunce, P.Krausa, K.McIntyre, S.Crowley,
  B.Morgan, A.Edwards, P.Giangrande, R.E. Phillips, &A.J.
  McMichael.
 Novel, cross-restricted, conserved and immunodominant cytotoxic T
  lymphocyte epitopes in slow HIV Type 1 infection.
 <i> AIDS Res and Hum Retroviruses</i> <b>12</b>:1691--1698, 1996b.

<P>[Goulder (1997a)]<br>
P.Goulder, A.Sewell, D.Lalloo, D.Price, J.Whelan, J.Evans,
  G.Taylor, G.Luzzi, P.Giangrande, R.Phillips, &A.J.
  McMichael.
 Patterns of immunodominance in HIV-1-specific cytotoxic T lymphocyte
  responses in two human histocompatibility leukocyte antigens (HLA)-identical
  siblings with HLA-A*0201 are influenced by epitope mutation.
 <i> J Exp Med</i> <b>8</b>:1423--33, 1997a.

<P>[Goulder (1997b)]<br>
P.J. Goulder, M.Bunce, G.Luzzi, R.E. Phillips, &A.J.
  McMichael.
 Potential underestimation of HLA-C-restricted cytotoxic T-lymphocyte
  responses.
 <i> AIDS</i> <b>11(15)</b>:1884--1886, 1997b.

<P>[Goulder (1997c)]<br>
P.J.R. Goulder, R.E. Phillips, R.A. Colbert, S.McAdam, G.Ogg,
  M.A. Nowak, P.Giangrande, G.Luzzi, B.Morgan, A.Edwards,
  A.McMichael, &S.Rowland-Jones.
 Late Escape from an immunodominant cytotoxic T-lymphocyte response
  associated with progression to AIDS.
 <i> Nature Med</i> <b>3</b>:212--216, 1997c.

<P>[Goulder (1997d)]<br>
P.J.R. Goulder, S.W. Reid, D.A. Price, C.A. O'Callaghan, A.J.
  McMichael, R.E. Phillips, &E.Y. Jones.
 Combined structural and immunological refinement of HIV-1 HLA-B8
  restricted cytotoxic T lymphocyte epitopes.
 <i> Eur J Immunol</i> <b>27</b>:1515--1521, 1997d.

<P>[Goulder (2000a)]<br>
P.J.R. Goulder, C.Brander, K.Annamalai, N.Mngqundaniso, U.Govender,
  Y.Tang, S.He, K.E. Hartman, C.A. O'Callaghan, G.S. Ogg, M.A. Altfeld,
  E.S. Rosenberg, H.Cao, S.A. Kalams, M.Hammond, M.Bunce, S.I. Pelton,
  S.A. Burchett, K.McIntosh, H.M. Coovadia, &B.D. Walker.
 Differential narrow focusing of immunodominant HIV gag-specific CTL
  responses in infected African and Caucasoid adults and children.
 <i> submitted 2000a.</i>

<P>[Goulder (2000b)]<br>
P.J.R. Goulder, Y.Tang, C.Brander, M.R. Betts, A.Trocha, S.He, E.S.
  Rosenberg, C.A.O. GrahamOgg, S.A. Kalams, R.E. McKinney, K.Mayer, R.A.
  Koup, S.I. Pelton, S.K. Burchett, K.McIntosh, &B.D. Walker.
 Functionally inert HIV-specific cytotoxic T lymphocytes do not play
  a major role in chronically infected adults and children.
 <i> submitted 2000b.</i>

<P>[Goulder (2000c)]<br>
P.J.R. Goulder, Y.Tang, S.I. Pelton, &B.D. Walker.
 HLA-B57-restricted CTL activity in a single infected subject towards
  two optimal HIV epitopes, one of which is entirely contained within the
  other.
 <i> J Virol 2000c.</i>

<P>[Haas (1996)]<br>
G.Haas, U.Plikat, P.Debre, M.Lucchiari, C.Katlama, Y.Dudoit,
  O.Bonduelle, M.Bauer, H.Ihlenfeldt, G.Jung, B.Maier,
  A.Meyerhans, &B.Autran.
 Dynamics of viral variants in HIV-1 Nef and specific cytotoxic T
  lymphocytes in vivo.
 <i> J Immunol</i> <b>157</b>:4212--4221, 1996.

<P>[Haas (1998)]<br>
G.Haas, A.Samri, E.Gomard, A.Hosmalin, J.Duntze, J.M. Bouley,
  H.G. Ihlenfeldt, C.Katlama, &B.Autran.
 Cytotoxic T-cell responses to HIV-1 reverse transcriptase, integrase
  and protease.
 <i> AIDS</i> <b>12(12)</b>:1427--36, 1998.

<P>[Harrer (1996a)]<br>
E.Harrer, T.Harrer, P.Barbosa, M.Feinberg, R.P. Johnson,
  S.Buchbinder, &B.D. Walker.
 Recognition of the highly conserved YMDD region in the human
  immunodeficiency virus type 1 reverse transcriptase by HLA-A2-restricted
  cytotoxic T lymphocytes from an asymptomatic long-term nonprogresser.
 <i> J Inf Dis</i> <b>173</b>:476--479, 1996a.

<P>[Harrer (1996b)]<br>
T.Harrer, E.Harrer, S.A. Kalams, P.Barbosa, A.Trocha, R.P.
  Johnson, T.Elbeik, M.B. Feinberg, S.P. Buchbinder, &B.D.
  Walker.
 Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing
  HIV-1 infection. Breadth and specificity of the response and relation to in
  vivo viral quasispecies in a person with prolonged infection and low viral
  load.
 <i> J Immunol</i> <b>156</b>:2616--2623, 1996b.

<P>[Harrer (1998)]<br>
T.Harrer, E.Harrer, P.Barbosa, F.Kaufmann, R.Wagner,
  S.Bruggemann, J.R. Kalden, M.Feinberg, R.P. Johnson,
  S.Buchbinder, &B.D. Walker.
 Recognition of two overlapping CTL epitopes in HIV-1 p17 by CTL from
  a long-term nonprogressing HIV-1-infected individual.
 <i> J Immunol</i> <b>161</b>:4875--81, 1998.

<P>[Hill (1992)]<br>
A.V. Hill, J.Elvin, A.C. Willis, M.Aidoo, C.E. Allsopp, F.M.
  Gotch, X.M. Gao, M.Takiguchi, B.M. Greenwood, &A.R. Townsend
  et al.
 Molecular analysis of the association of HLA-B53 and resistance to
  severe malaria (see comments).
 <i> Nature</i> <b>360</b>:434--9, 1992.

<P>[Ikeda-Moore (1998)]<br>
Y.Ikeda-Moore, H.Tomiyama, M.Ibe, S.Oka, K.Miwa, Y.Kaneko, \&
  M.Takiguchi.
 Identification of a novel HLA-A24-restricted cytotoxic T-lymphocyte
  epitope derived from HIV-1 Gag protein.
 <i> AIDS</i> <b>12</b>:2073--4, 1998.

<P>[Jardetzky (1991)]<br>
T.S. Jardetzky, W.S. Lane, R.A. Robinson, D.R. Madden, &D.C.
  Wiley.
 Identification of self peptides bound to purified HLA-B27.
 <i> Nature</i> <b>353</b>:326--9, 1991.

<P>[Johnson (1991)]<br>
R.P. Johnson, A.Trocha, L.Yang, G.P. Mazzara, D.L. Panicali,
  T.M. Buchanan, &B.D. Walker.
 HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly
  conserved epitopes. Fine specificity of the gag-specific response defined by
  using unstimulated peripheral blood mononuclear cells and cloned effector
  cells.
 <i> J Immunol</i> <b>147</b>:1512--1521, 1991.

<P>[Johnson (1992)]<br>
R.P. Johnson, A.Trocha, T.M. Buchanan, &B.D. Walker.
 Identification of overlapping HLA class I-restricted cytotoxic
  T-cell epitopes in a conserved region of the human immunodeficiency virus
  type 1 envelope glycoprotein: definition of minimum epitopes and analysis of
  the effects of sequence variation.
 <i> J Exp Med</i> <b>175</b>:961--971, 1992.

<P>[Johnson (1993)]<br>
R.P. Johnson, A.Trocha, T.M. Buchanan, &B.D. Walker.
 Recognition of a highly conserved region of human immunodeficiency
  virus type 1 gp120 by an HLA-Cw4-restricted cytotoxic T-lymphocyte clone.
 <i> J Virol</i> <b>67</b>:438--445, 1993.

<P>[Johnson (1994)]<br>
R.P. Johnson, S.A. Hammond, A.Trocha, R.F. Siliciano, &B.D.
  Walker.
 Induction of a major histocompatibility complex class I-restricted
  cytotoxic T-lymphocyte response to a highly conserved region of human
  immunodeficiency virus type 1 (HIV-1) gp120 in seronegative humans immunized
  with a candidate HIV-1 vaccine.
 <i> J Virol</i> <b>68</b>:3145--3153, 1994.

<P>[Johnson &Walker(1994)]<br>
R.P. Johnson &B.D. Walker.
 CTL in HIV-1 infection: Responses to structural proteins.
 <i> Curr Topics Microbiol Immunol</i> <b>189</b>:35--63, 1994.

<P>[Klenerman (1996)]<br>
P.Klenerman, G.Luzzi, K.McIntyre, R.Phillips, &A.McMichael.
 Identification of a novel HLA-A25 restricted epitope in a conserved
  region of p24 gag (positions 71-80).
 <i> AIDS</i> <b>10</b>:348--350, 1996.

<P>[Koenig (1990)]<br>
S.Koenig, T.R. Fuerst, L.V. Wood, R.M. Woods, J.A. Suzich, G.M.
  Jones, V.F. de la Cruz, R.T.D. Jr., S.Venkatesan, B.Moss, W.E.
  Biddison, &A.S. Fauci.
 Mapping the fine specificity of a cytotoxic T-cell response to HIV-1
  Nef protein.
 <i> J Immunol</i> <b>145</b>:127--135, 1990.

<P>[Lieberman (1992)]<br>
J.Lieberman, J.A. Fabry, M.-C. Kuo, P.Earl, B.Moss, &P.R.
  Skolnik.
 Cytotoxic T lymphocytes from HIV-1 seropositive individuals
  recognize immunodominant epitopes in gp160 and reverse transcriptase.
 <i> J Immunol</i> <b>148</b>:2738--2747, 1992.

<P>[Maier (1994)]<br>
R.Maier, K.Falk, O.Rotzschke, B.Maier, V.Gnau, S.Stevanovic,
  G.Jung, H.G. Rammensee, &A.Meyerhans.
 Peptide motifs of HLA-A3, -A24, and -B7 molecules as determined by
  pool sequencing.
 <i> Immunogenetics</i> <b>40</b>:306--8, 1994.

<P>[McKinney (1999)]<br>
D.McKinney, D.Lewinson, S.Riddell, P.Greenberg, &D.Mosier.
 The Antiviral Activity of HIV-Specific CD8+ CTL clones is limited by
  elimination due to encounter with HIV-infected targets.
 <i> J. Immuno</i> <b>163</b>:861--7, 1999.

<P>[McMichael &O'Callaghan(1998)]<br>
A.J. McMichael &C.A. O'Callaghan.
 A New Look at T Cells.
 <i> J Exp Med</i> <b>187(9)</b>:1367--1371, 1998.

<P>[Nixon (1988)]<br>
D.Nixon, A.Townsend, J.Elvin, C.Rizza, J.Gallway, \&
  A.McMichael.
 HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant
  vaccinia virus and synthetic peptides.
 <i> Nature</i> <b>336</b>:484--487, 1988.

<P>[Nixon (1999)]<br>
D.F. Nixon, D.Douek, P.J. Kuebler, X.Jin, M.Vesanen,
  S.Bonhoeffer, Y.Cao, R.A. Koup, D.D. Ho, &M.Markowitz.
 Molecular tracking of an Human Immunodeficiency Virus nef specific
  cytotoxic T-cell clone shows persistence of clone-specific T-cell receptor
  DNA but not mRNA following early combination antiretroviral therapy.
 <i> Immunol Lett</i> <b>66</b>:219--28, 1999.

<P>[Ogg (1998)]<br>
G.S. Ogg, X.Jin, S.Bonhoeffer, P.R. Dunbar, M.A. Nowak,
  S.Monard, J.P. Segal, Y.Cao, S.L. Rowland-Jones, V.Cerundolo,
  A.Hurley, M.Markowitz, D.D. Ho, D.F. Nixon, &A.J. McMichael.
 Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma
  load of viral RNA.
 <i> Science</i> <b>279</b>:2103--6, 1998.

<P>[Ogg (1999)]Ogg99
G.S. Ogg, X.Jin, S.Bonhoeffer, P.Moss, M.A. Nowak, S.Monard,
  J.P. Segal, Y.Cao, S.L. Rowland-Jones, A.Hurley, M.Markowitz,
  D.D. Ho, A.J. McMichael, &D.F. Nixon.
 Decay kinetics of human immunodeficiency virus-specific effector
  cytotoxic T lymphocytes after combination antiretroviral therapy.
 <i> J Virol</i> <b>73</b>:797--800, 1999.

<P>[Parker (1992)]<br>
K.C. Parker, M.A. Bednarek, L.K. Hull, U.Utz, B.C. H.J.
  Zweerink, W.E. Biddison, &J.E. Coligan.
 Sequence motifs important for peptide binding to the human MHC class
  I molecule, HLA-A2.
 <i> J Immunol</i> <b>149</b>, 1992.

<P>[Parker (1994)]<br>
K.C. Parker, M.A. Bednarek, &J.E. Coligan.
 Scheme for ranking potential HLA-A2 binding peptides based on
  independent binding of individual peptide side-chains.
 <i> J Immunol</i> <b>152</b>, 1994.

<P>[Price (1997)]<br>
D.A. Price, P.J. Goulder, P.Klenerman, A.K. Sewell, P.J.
  Easterbrook, M.Troop, C.R. Bangham, &R.E. Phillips.
 Positive selection of HIV-1 cytotoxic T lymphocyte escape variants
  during primary infection.
 <i> Proc Natl Acad Sci USA</i> <b>94</b>:1890--5, 1997.

<P>[Rammensee (1995)]<br>
H.-G. Rammensee, T.Friede, &S.Stevanovic.
 MHC ligands and peptide motifs: first listing.
 <i> Immunogenetics</i> <b>41</b>:178--228, 1995.

<P>[Rammensee (1999)]<br>
H.Rammensee, J.Bachmann, N.Emmerich, &S.Stevanovic.
 SYFPEITHI: An Internet Database for MHC Ligands and Peptide Motifs.
 <i>  1999.</i>

<P>[Rowland-Jones (1993)]<br>
S.L. Rowland-Jones, S.H. Powis, J.Sutton, I.Mockridge, F.M.
  Gotch, N.Murray, A.B. Hill, W.M. Rosenberg, J.Trowsdale, \&
  A.J. McMichael.
 An antigen processing polymorphism revealed by HLA-B8-restricted
  cytotoxic T lymphocytes which does not correlate with TAP gene polymorphism.
 <i> Eur J Immunol</i> <b>23</b>:1999--2004, 1993.

<P>[Rowland-Jones (1995)]<br>
S.L. Rowland-Jones, J.Sutton, K.Ariyoshi, T.Dong and , F.Gotch,
  S.McAdam, D.Whitby, S.Sabally, A.Gallimore, T.Corrah,
  M.Takiguchi, T.Schultz, A.McMichael, &H.Whittle.
 HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian
  women.
 <i> Nature Medicine</i> <b>1</b>:59--64, 1995.

<P>[Rowland-Jones (1998)]<br>
S.L. Rowland-Jones, T.Dong, K.R. Fowke, J.Kimani, P.Krausa,
  H.Newell, T.Blanchard, K.Ariyoshi, J.Oyugi, E.Ngugi,
  J.Bwayo, K.S. MacDonald, A.J. McMichael, &F.A. Plummer.
 Cytotoxic T cell responses to multiple conserved HIV epitopes in
  HIV- resistant prostitutes in Nairobi [see comments].
 <i> J Clin Invest</i> <b>102</b>:1758--65, 1998.

<P>[Safrit (1994a)]<br>
J.T. Safrit, C.A. Andrews, T.Zhu, D.D. Ho, &R.A. Koup.
 Characterization of human immunodeficiency virus type 1-specific
  cytotoxic T lymphocyte clones isolated during acute seroconversion:
  recognition of autologous virus sequences within a conserved immunodominant
  epitope.
 <i> J Exp Med</i> <b>179</b>:463--472, 1994a.

<P>[Safrit (1994b)]<br>
J.T. Safrit, A.Y. Lee, C.A. Andrews, &R.A. Koup.
 A region of the Third Variable Loop of HIV-1 gp120 is recognized by
  HLA-B7-Restricted CTLs from two acute seroconversion patients.
 <i> J Immunol</i> <b>153</b>:3822--3830, 1994b.

<P>[Schmitz (1999)]<br>
J.E. Schmitz, M.J. Kuroda, S.Santra, V.G. Sasseville, M.A.
  Simon, M.A. Lifton, P.Racz, K.Tenner-Racz, M.Dalesandro, B.J.
  Scallon, J.Ghrayeb, M.A. Forman, D.C. Montefiori, E.P. Rieber,
  N.L. Letvin, &K.A. Reimann.
 Control of viremia in simian immunodeficiency virus infection by
  CD8+ lymphocytes.
 <i> Science</i> <b>283</b>:857--60, 1999.

<P>[Seeger (1998)]<br>
F.H. Seeger, D.Arnold, T.Dumrese, H.de la Salle, D.Fricker,
  H.Schild, H.G. Rammensee, &S.Stevanovic.
 The HLA-B* 1516 motif demonstrates HLA-B-specific P2 pocket
  characteristics.
 <i> Immunogenetics</i> <b>48</b>:156--60, 1998.

<P>[Shankar (1996)]<br>
P.Shankar, J.A. Fabry, D.M. Fong, &J.Lieberman.
 Three regions of HIV-1 gp160 contain clusters of immunodominant CTL
  epitopes.
 <i> Immunol Lett</i> <b>52</b>:23--30, 1996.

<P>[Shiga (1996)]<br>
H.Shiga, T.Shioda, H.Tomiyama, Y.Takamiya, S.Oka, S.Kimura,
  Y.Yamaguchi, T.Gojoubori, H.G. Rammensee, K.Miwa, \&
  M.Takiguchi.
 Identification of multiple HIV-1 cytotoxic T-cell epitopes presented
  by human leukocyte antigen B35 molecule.
 <i> AIDS</i> <b>10</b>:1075--1083, 1996.

<P>[Sipsas (1997)]<br>
N.V. Sipsas, S.A. Kalams, A.Trocha, S.He, W.A. Blattner, B.D.
  Walker, &R.P. Johnson.
 Identification of type-specific cytotoxic T lymphocyte responses to
  homologous viral proteins in laboratory workers accidentally infected with
  HIV-1.
 <i> J Clin Invest</i> <b>99</b>:752--62, 1997.

<P>[Sutton (1993)]<br>
J.Sutton, S.Rowland-Jones, W.Rosenberg, D.Nixon, F.Gotch, X.-M.
  Gao, N.Murray, A.Spoonas, P.Driscoll, M.Smith, A.Willis, \&
  A.McMichael.
 A sequence pattern for peptides presented to cytotoxic T lymphocytes
  by HLA B8 revealed by analysis of epitopes and eluted peptides.
 <i> Eur J Immunol</i> <b>23</b>:447--453, 1993.

<P>[Takahashi (1991)]<br>
K.Takahashi, L.-C. Dai, T.R. Fuerst, W.E. Biddison, P.L. Earl,
  B.Moss, &F.A. Ennis.
 Specific lysis of human immunodeficiency virus type 1-infected cells
  by a HLA-A3.1-restricted CD8+ cytotoxic T-lymphocyte clone that recognizes a
  conserved peptide sequence within the gp41 subunit of the envelope protein.
 <i> Proc Natl Acad Sci USA</i> <b>88</b>:10277--10281, 1991.

<P>[Tang (1999)]<br>
J.Tang, C.Costello, I.P. Keet, C.Rivers, S.Leblanc, E.Karita,
  S.Allen, &R.A. Kaslow.
 HLA class I homozygosity accelerates disease progression in human.
 <i> AIDS Res Hum Retroviruses</i> <b>15</b>:317--24, 1999.

<P>[Threlkeld (1997)]<br>
S.C. Threlkeld, P.A. Wentworth, S.A. Kalams, B.M. Wilkes, D.J.
  Ruhl, E.Kepgh, J.Sidney, S.Southwood, B.D. Walker, \&
  A.Sette.
 Degenerate and promiscuous recognition by CTL of peptides presented
  by the MHC class I A3-like superfamily.
 <i> J Immunol</i> <b>159(4)</b>:1648--1657, 1997.

<P>[Tsomides (1991)]<br>
T.J. Tsomides, B.D. Walker, &H.N. Eisen.
 An optimal viral peptide recognized by CD8+ T-cells binds very
  tightly to the restricting class I major histocompatibility complex protein
  on intact cells but not to the purified class I protein.
 <i> Proc Natl Acad Sci USA</i> <b>88</b>:11276--11280, 1991.

<P>[van Baalen (1996)]<br>
C.A. van Baalen, M.R. Klein, R.C. Huisman, M.E. Dings, S.R.
  Kerkhof Garde, A.M. Geretti, R.Gruters, C.A. van Els,
  F.Miedema, &A.D. Osterhaus.
 Fine-specificity of cytotoxic T lymphocytes which recognize
  conserved epitopes of the Gag protein of human immunodeficiency virus type
  1.
 <i> J Gen Virol</i> <b>77</b>:1659--1665, 1996.

<P>[van der Burg (1997)]<br>
S.H. van der Burg, M.R. Klein, O.Pontesilli, A.M. Holwerda,
  J.Drijfhout, W.M. Kast, F.Miedema, &C.J.M. Melief.
 HIV-1 reverse transcriptase-specific CTL against conserved epitopes
  do not protect against progression to AIDS.
 <i> J Immunol</i> <b>159</b>:3648--3654, 1997.

<P>[Walker (1989)]<br>
B.D. Walker, C.Flexner, K.Birch-Limberger, L.Fisher, T.J.
  Paradis, A.Aldovini, R.Young, B.Moss, &R.T. Schooley.
 Long-term culture and fine specificity of human cytotoxic
  T-lymphocyte clones reactive with human immunodeficiency virus type 1.
 <i> Proc Natl Acad Sci USA</i> <b>86</b>:9514--9518, 1989.

<P>[Wilson (1997)]<br>
C.C. Wilson, S.A. Kalams, B.M. Wilkes, D.J. Ruhl, F.Gao, B.H.
  Hahn, I.C. Hanson, K.Luzuriaga, S.Wolinsky, R.Koup, S.P.
  Buchbinder, R.P. Johnson, &B.D. Walker.
 Overlapping epitopes in human immunodeficiency virus type 1 gp120
  presented by HLA A, B, and C molecules: effects of viral variation on
  cytotoxic T-lymphocyte recognition.
 <i> J Virol</i> <b>71</b>:1256--64, 1997.

<P>[Wilson (1999)]<br>
C.C. Wilson, R.C. Brown, B.T. Korber, B.M. Wilkes, D.J. Ruhl,
  D.Sakamoto, K.Kunstman, K.Luzuriaga, I.C. Hanson, S.M.
  Widmayer, A.Wiznia, S.Clapp, A.J. Ammann, R.A. Koup, S.M.
  Wolinsky, &B.D. Walker.
 Frequent detection of escape from cytotoxic T-lymphocyte recognition
  in perinatal human immunodeficiency virus (HIV) type 1 transmission: the
  ariel project for the prevention of transmission of HIV from mother to
  infant.
 <i> J Virol</i> <b>73</b>:3975--85, 1999.

<P>[Zhang (1993)]<br>
Q.-I. Zhang, R.Gavioli, G.Klein, &M.G. Masucci.
 An HLA-All-specific motif in nonamer peptides derived from viral and
  cellular proteins.
 <i> Proc Natl Acad Sci USA</i> <b>90</b>:2217--2221, 1993.


</body>
</html>
</td></tr>
	    <tr><td><table bgcolor="white" width="100%" align="center" cellpadding="0" cellspacing="0" border="0">
  <tr><td>&nbsp;</td></tr>
  <tr><td colspan=2 align=center>Questions or comments? Contact us at <a href="mailto:seq-info@t10.lanl.gov"><font color="#8f8fbd" face="helvetica">seq-info@t10.lanl.gov</font></a></td></tr>
  <tr><td>&nbsp;</td></tr>
</table>



</td></tr>
	  </table>  
        </td>
      </tr>	
    </table>
  </body>
</html>      

<!-- no autohandlers upstream -->


